Surrozen (SRZN) EVP Li Yang awarded 100,950 options and 100,950 RSUs

Rhea-AI Filing Summary

Surrozen, Inc. executive Li Yang received new equity awards consisting of stock options and restricted stock units. On February 17, 2026, Yang was granted options to purchase 100,950 shares of common stock at an exercise price of $0.00 per share and 100,950 restricted stock units.

The stock options vest over four years in 48 equal monthly installments starting February 1, 2026, conditioned on continued service. The RSUs vest in four equal annual installments beginning February 1, 2026, also subject to continued service. These awards represent direct ownership incentives rather than open-market share purchases.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Li Yang

Role Exec. Vice President, Research

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	100,950	$0.00	--
Grant/Award	Restricted Stock Unit	100,950	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 100,950 shares (Direct); Restricted Stock Unit — 100,950 shares (Direct)

Footnotes (1)

1. The shares subject to the option award vest over a four-year period in 48 equal monthly installments measured from February 1, 2026, subject to the reporting person's continued service through the applicable vesting date. Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the RSUs vest in four equal annual installments starting on February 1, 2026, subject to the reporting person's continued service through the applicable vesting date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Li Yang

(Last) (First) (Middle)

C/O SURROZEN, INC.

171 OYSTER POINT BLVD., SUITE 400

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Surrozen, Inc./DE [ SRZN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. Vice President, Research

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$24.53	02/17/2026		A		100,950		(1)	02/16/2036	Common Stock	100,950	$0	100,950	D
Restricted Stock Unit	(2)	02/17/2026		A		100,950		(3)	(3)	Common Stock	100,950	$0	100,950	D

Explanation of Responses:

1. The shares subject to the option award vest over a four-year period in 48 equal monthly installments measured from February 1, 2026, subject to the reporting person's continued service through the applicable vesting date.

2. Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock.

3. The shares subject to the RSUs vest in four equal annual installments starting on February 1, 2026, subject to the reporting person's continued service through the applicable vesting date.

	/s/Charles Williams, Attorney-in-Fact for Yang Li	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Surrozen (SRZN) executive Li Yang report in this Form 4 filing?

Li Yang reported equity awards from Surrozen, including 100,950 stock options and 100,950 restricted stock units. These are grants, not open-market trades, and are tied to continued employment and long-term company performance incentives.

How many Surrozen (SRZN) stock options were granted to Li Yang and how do they vest?

Li Yang received 100,950 employee stock options. These options vest over a four-year period in 48 equal monthly installments beginning February 1, 2026, as long as Yang continues providing service through each applicable vesting date.

What restricted stock units (RSUs) did Li Yang receive from Surrozen (SRZN)?

Li Yang was granted 100,950 restricted stock units. Each RSU represents the right to receive one share of Surrozen common stock. The RSUs vest in four equal annual installments starting on February 1, 2026, subject to continued service.

Are Li Yang’s Surrozen (SRZN) equity awards immediate shares or contingent rights?

The awards are contingent rights. The options give a right to buy shares over time, while each RSU represents a right to receive one share. Both vest according to multi-year schedules tied to continued service with Surrozen.

Does this Surrozen (SRZN) Form 4 reflect insider buying or selling on the open market?

No, the Form 4 reflects grants of options and RSUs, not open-market buying or selling. The reported transactions are compensation awards with vesting conditions, rather than discretionary trading in Surrozen’s common stock.